Chris Aiken, MD

Zuranolone: 10 Questions about a New Antidepressant

August 14, 2023

Zuranolone (Zurzuvae) is newly approved for postpartum depression, but does it work in regular depression? And why did they put so many “Zs” in the name?

Clinical Update

Stimulant Dosing Limits

August 7, 2023

Chris Aiken, MD and Kelvin Quiñones-Laracuente, MD, PhD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Kelvin Quiñones-Laracuente, MD, PhD. Psychiatry resident, NYU Langone Medical Center.

Drs. Aiken and Quiñones-Laracuente have no financial relationships with companies related to this material.

Dosing is not a collaborative venture when it comes to controlled substances, and here we look for the safe upper limits of stimulant dosing.

How to Set Behavioral Goals in the Med Visit

July 31, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Do you see patients who have no motivation to do anything? Michael Posternak has a novel strategy for working with this depressive symptom during the medication visit in this special tribute to the late psychiatrist.

Bipolar Treatment Upgrade Part II

July 17, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates on lithium from the 2023 International Bipolar Conference.

Bipolar Treatment Upgrade Part I

July 10, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates from the 2023 International Bipolar Conference, including new diagnostic tools for bipolar disorder. Stanford researchers propose a new subtype of depression.

Slow Fade: Homosexuality and the DSM Part 2

July 3, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

50 years ago the APA removed code 302.0: Homosexuality from the DSM. Almost.

Clinical Update

Auvelity: A Fast-Acting Antidepressant?

July 3, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how to use it and the pros/cons of generic substitution.

CLINICAL UPDATE

How to Advise Clients About Light Therapy

June 30, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Light therapy is an effective treatment for winter and nonseasonal depression as well as other related disorders. To use this therapy, you’ll need to know a few basics.

Stahl Goes Generic: 3 Reasons to use MAOIs

June 12, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Stephen Stahl steps down from the industry-sponsored podium to remind us of 3 reasons to use an MAOI: Atypical depression, treatment-resistant depression, and social anxiety disorder.

Clinical Update

A Psychedelic Primer

June 1, 2023

Chris Aiken, MD and Garrett Rossi, MD.

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

The authors have no financial relationships with companies related to this material.

How did a dangerous drug of abuse become a therapeutic panacea?